Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

This study has been completed.
Dermatology Associates, PLLC
Genentech, Inc.
Information provided by:
Derm Research, PLLC Identifier:
First received: March 10, 2006
Last updated: July 12, 2007
Last verified: July 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given